The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore ...

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

Catalent, a global contract development and manufacturing organization (CDMO), has been recognized with two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and Social ...

The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change. Our program ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Adaptive logistics are vital for clinical trials, but there are challenges in navigating complexities of regulations and ...

The FDA rejected the company’s initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.